Scinai Immunotherapeutics Ltd. team is excited to attend the BIOEurope congress in  Stockholm, Sweden, from November 4–6, 2024. We invite investors, partners, and biopharma innovators to meet us!

Stop by our booth #150 to:

⚛️ Hear more about our promising product pipeline, including an innovative Anti-IL-17A/F #sdAb , addressing the significant unmet need of mild to moderate plaque psoriasis patients.

📈 Discover how our end-to-end boutique CDMO BioServices can optimize your process development and manufacturing and streamline your project- from lab to vial.

🤝 Meet our distinguished Biopharma team including CEO, Amir Reichman; and CTO Dalit Fischer ready to answer all your questions.

We look forward to seeing you there. Reach out to us to schedule a meeting at bd@scinai.com